Navigation Links
Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
Date:4/16/2012

EXTON, Pa., April 16, 2012 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy. MORAb-004 is a monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1).

The trial is a randomized, double-blind, placebo-controlled study to assess the efficacy and safety of single agent MORAb-004 plus best supportive care as determined by progression-free survival in patients with chemorefractory metastatic colorectal cancer. Secondary objectives include assessment of an overall survival benefit, identification of biomarkers to predict efficacy, and safety of single agent MORAb-004.

Morphotek expects to enroll up to 160 patients in this study, which is being conducted at clinical centers in the United States.  As part of the trial, patient tumors and plasma samples will be tested for endosialin/TEM-1 and/or proteins within its pathway to determine if the pattern of expression relates to or determines clinical effect. The goal of these investigations is to identify those patients who had a clinically meaningful response to MORAb-004.

"We are excited to have initiated this Phase II study of MORAb-004 in metastatic colorectal cancer," stated Christina Coughlin, M.D., Ph.D., Senior Director of Clinical Development at Morphotek. "New agents are needed for the treatment of metastatic colorectal cancer.  The treatment of chemorefractory colorectal cancer remains an area of significant unmet medical need in the field of oncology. We are pleased to have the opportunity to collaborate with several key experts in this disease setting."

MORAb-004 is a humanized monoclonal antibody specific for endosialin/TEM-1 protein.  The target is found to be expressed on the cell surface of cells call
'/>"/>

SOURCE Morphotek(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc.
2. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:4/16/2014)... Ariz. April 15, 2014 The Translational Genomics ... at their annual Founders Dinner for their support of ... event took place March 28 in Scottsdale. , Catherine ... Ivy Foundation, received TGen,s John S. McCain Leadership Award, ...
(Date:4/15/2014)... and pre-diabetes in the United States have nearly doubled since ... of Public Health, with obesity apparently to blame for the ... disease has not hit all groups equally, with alarming increases ... to new research reported in the April 15, 2014 issue ...
(Date:4/14/2014)... , Significant advances have been made in chemotherapy over ... while avoiding healthy tissues continues to be a major ... targeted drug delivery, including the use of nanocarriers, or ... specific locations in the body. , The catch? These ...
(Date:4/14/2014)... IL A new study shows that moderate to severe obstructive ... cancer and death. , Results of the 20-year follow-up study show ... times more likely to die (hazard ratio = 4.2), nearly four ... times more likely to die from cancer (HR = 3.4), and ...
(Date:4/14/2014)... that the molecule, called microRNA 135b, is a vital ... the growth of bowel cancers. , Drugs targeted at ... cancer-causing mutations at once, while tests for it could ... believe. , The research was carried out by an ...
Breaking Medicine News(10 mins):Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Nano shake-up 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:'MicroRNA' could be key target for bowel cancer treatment 2
... thousands San,Diegans flee the flames, they,re trying to make sense ... These wildfires have created a,tremendous amount of stress and anxiety ... to come, many may begin to have some of,these common ... -- Fear and anxiety about the future -- Disorientation; ...
... Compound Problems With Governor,s Mandatory Health Insurance Plan, ... released today by the Schwarzenegger Administration fail to,protect ... insurers,to decide which policies to cancel without prior ... and Consumer Rights (FTCR).,FTCR said that the weak ...
... Reports Day or Night, CLEVELAND, Oct. 23 ... it has expanded its subspecialty,teleradiology business model to ... its acquisition of Apex Radiology, Coral Springs, FL. ... largest teleradiology,provider of final reports, as well as ...
... YDNT ) today announced results for the quarter ... the third quarter were $24.7 million, increasing 3.5% over,the ... Income from,operations decreased 16.8% to $5.2 million from $6.2 ... decreased 22.1% from $3.9 million in the,prior year. Diluted ...
... are the most dependent on,others and the ones the ... trauma expert. "Why do children exhibit psychological trauma? ... security of their parents and the predictability,of their physical ... Angeles psychologist Robert R. Butterworth, Ph.D. Dr. Butterworth ...
... How to Help Children Cope, WESTPORT, Conn., Oct. ... to disasters and works to improve the,lives of children ... experts,to assist children and families affected by the devastating ... posted to San Diego, will provide assistance to,children and ...
Cached Medicine News:Health News:Coping with the Stress of Natural Disasters 2Health News:Draft Rules Won't Stop Insurers' Illegal Cancellations of Health Policies 2Health News:Draft Rules Won't Stop Insurers' Illegal Cancellations of Health Policies 3Health News:Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology 2Health News:Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology 3Health News:Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend 2Health News:Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend 3Health News:Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend 4Health News:Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend 5Health News:Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend 6Health News:California Wildfires - Psychological Effects; Children ... Psychologist Is Available to Discuss Trauma 2Health News:Save the Children to Help Youngsters Impacted by California Wildfires 2Health News:Save the Children to Help Youngsters Impacted by California Wildfires 3Health News:Save the Children to Help Youngsters Impacted by California Wildfires 4Health News:Save the Children to Help Youngsters Impacted by California Wildfires 5
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
... Combines BchiVac V-500 with Vacuum Controller ... controls vacuum levels from Compact Housing ... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
Medicine Products: